Researchers Study Alzheimer’s Disease in People with Down Syndrome

Studies May Lead to Earlier Diagnosis and Treatment of Alzheimer’s Disease in All Patients

CUMC Newsroom
November 24, 2015

New studies at Columbia are designed to explain why some people with Down syndrome develop Alzheimer’s disease earlier than others and why some people with Down syndrome may never develop the disease. With funding from the NIH, Nicole Schupf, PhD, DrPH, will identify biomarkers for Alzheimer’s disease in people with Down syndrome, which may help researchers predict who will develop Alzheimer’s in all groups of people. Dr. Schupf is professor of epidemiology at CUMC in Columbia’s Taub Institute for Research on Alzheimer’s Disease and the Aging Brain and the Departments of Neurology and Psychiatry.  [read more]